Currently holds a position at Evelo Biosciences Inc
Position | Company | Period |
---|---|---|
Chairman of the Board | Evelo Biosciences Inc | Sept. 17, 2019 - |
Director | Evelo Biosciences Inc | March 1, 2017 - Sept. 17, 2019 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-05-31 | 2022-05-27 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
17,123
+25.6%
1.4625,000 USD |
17,123 +25.6% | 1.46 | 25,000 USD | |
2022-04-22 | 2022-04-21 |
Rubius Therapeutics Inc
(RUBY)
|
B Purchase |
30,000
+0.6%
1.4443,329 USD |
30,000 +0.6% | 1.44 | 43,329 USD | |
2022-03-18 | 2022-03-16 |
Axcella Health Inc
(AXLA)
|
B Purchase |
26,178
+19.4%
1.9150,000 USD |
26,178 +19.4% | 1.91 | 50,000 USD | |
2021-02-16 | 2021-02-11 |
Rubius Therapeutics Inc
(RUBY)
|
PS Planned sale |
26,704
-0.6%
14.93398,560 USD |
26,704 -0.6% | 14.93 | 398,560 USD | |
2021-02-10 | 2021-02-10 |
Rubius Therapeutics Inc
(RUBY)
|
PS Planned sale |
7,404
-0.2%
14.79109,525 USD |
7,404 -0.2% | 14.79 | 109,525 USD | |
2021-02-10 | 2021-02-09 |
Rubius Therapeutics Inc
(RUBY)
|
PS Planned sale |
2,100
-0.0%
14.8331,146 USD |
2,100 -0.0% | 14.83 | 31,146 USD | |
2021-02-10 | 2021-02-08 |
Rubius Therapeutics Inc
(RUBY)
|
PS Planned sale |
89,233
-1.9%
14.881,328,117 USD |
89,233 -1.9% | 14.88 | 1,328,117 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
200
+1.1%
7.021,404 USD |
200 +1.1% | 7.02 | 1,404 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
500
+2.9%
6.983,490 USD |
500 +2.9% | 6.98 | 3,490 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
1,000
+6.2%
6.916,910 USD |
1,000 +6.2% | 6.91 | 6,910 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
800
+5.3%
7.165,728 USD |
800 +5.3% | 7.16 | 5,728 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
4,970
+48.6%
6.4932,255 USD |
4,970 +48.6% | 6.49 | 32,255 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
30
+0.3%
6.45194 USD |
30 +0.3% | 6.45 | 194 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
200
+2.0%
6.401,280 USD |
200 +2.0% | 6.40 | 1,280 USD | |
2020-09-01 | 2020-08-31 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
1,000
+11.1%
4.584,580 USD |
1,000 +11.1% | 4.58 | 4,580 USD | |
2020-09-01 | 2020-08-31 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
1,000
+12.5%
4.484,480 USD |
1,000 +12.5% | 4.48 | 4,480 USD | |
2020-09-01 | 2020-08-31 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
1,000
+14.3%
4.474,470 USD |
1,000 +14.3% | 4.47 | 4,470 USD | |
2020-09-01 | 2020-08-31 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
2,752
+64.8%
4.4612,274 USD |
2,752 +64.8% | 4.46 | 12,274 USD | |
2020-09-01 | 2020-08-28 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
3,248
+324.8%
4.4014,291 USD |
3,248 +324.8% | 4.40 | 14,291 USD | |
2020-09-01 | 2020-08-28 |
Evelo Biosciences Inc
(EVLO)
|
B Purchase |
1,000
+inf%
4.344,340 USD |
1,000 +inf% | 4.34 | 4,340 USD | |
2020-05-20 | 2020-05-18 |
Axcella Health Inc
(AXLA)
|
B Purchase |
50,000
+73.4%
4.75237,500 USD |
50,000 +73.4% | 4.75 | 237,500 USD | |
2020-03-19 | 2020-03-17 |
Rubius Therapeutics Inc
(RUBY)
|
B Purchase |
5,000
+0.1%
3.7618,800 USD |
5,000 +0.1% | 3.76 | 18,800 USD | |
2020-03-17 | 2020-03-13 |
Rubius Therapeutics Inc
(RUBY)
|
B Purchase |
5,000
+0.1%
4.0020,000 USD |
5,000 +0.1% | 4.00 | 20,000 USD | |
2020-03-17 | 2020-03-13 |
Rubius Therapeutics Inc
(RUBY)
|
B Purchase |
5,000
+0.1%
3.8219,100 USD |
5,000 +0.1% | 3.82 | 19,100 USD | |
2020-03-02 | 2020-02-28 |
Axcella Health Inc
(AXLA)
|
B Purchase |
2,005
+3.0%
3.757,519 USD |
2,005 +3.0% | 3.75 | 7,519 USD | |
2020-03-02 | 2020-02-27 |
Axcella Health Inc
(AXLA)
|
B Purchase |
12,800
+24.0%
3.6546,720 USD |
12,800 +24.0% | 3.65 | 46,720 USD | |
2019-07-18 | 2019-07-17 |
Axcella Health Inc
(AXLA)
|
B Purchase |
1,000
+3.3%
7.557,550 USD |
1,000 +3.3% | 7.55 | 7,550 USD | |
2019-07-10 | 2019-07-10 |
Axcella Health Inc
(AXLA)
|
B Purchase |
1,322
+4.6%
8.0710,669 USD |
1,322 +4.6% | 8.07 | 10,669 USD | |
2019-07-10 | 2019-07-09 |
Axcella Health Inc
(AXLA)
|
B Purchase |
4,200
+16.9%
8.2434,608 USD |
4,200 +16.9% | 8.24 | 34,608 USD | |
2019-07-10 | 2019-07-08 |
Axcella Health Inc
(AXLA)
|
B Purchase |
274
+1.1%
9.002,466 USD |
274 +1.1% | 9.00 | 2,466 USD | |
2019-07-03 | 2019-07-03 |
Axcella Health Inc
(AXLA)
|
B Purchase |
56
+0.3%
8.99503 USD |
56 +0.3% | 8.99 | 503 USD | |
2019-07-03 | 2019-07-02 |
Axcella Health Inc
(AXLA)
|
B Purchase |
3,500
+22.6%
8.7730,678 USD |
3,500 +22.6% | 8.77 | 30,678 USD | |
2019-07-03 | 2019-07-01 |
Axcella Health Inc
(AXLA)
|
B Purchase |
1,000
+6.9%
8.748,735 USD |
1,000 +6.9% | 8.74 | 8,735 USD | |
2019-07-01 | 2019-06-28 |
Axcella Health Inc
(AXLA)
|
B Purchase |
5,400
+37.0%
10.0454,216 USD |
5,400 +37.0% | 10.04 | 54,216 USD | |
2019-07-01 | 2019-06-27 |
Axcella Health Inc
(AXLA)
|
B Purchase |
100
+0.7%
9.15915 USD |
100 +0.7% | 9.15 | 915 USD | |
2019-06-27 | 2019-06-26 |
Axcella Health Inc
(AXLA)
|
B Purchase |
14,500
+inf%
9.57138,765 USD |
14,500 +inf% | 9.57 | 138,765 USD |